February 9th 2019 was an important date for anyone involved in the distribution of medicines in Europe. From this day the European Falsified Medicine Directive (FMD) (2011/62/EU) took effect. CHAPPER healthcare invested in new FMD hardware and software to ensure that they were FMD compliant, in-line with the directive, by the 9th February.
The Directive, which is now a legal requirement, helps manufacturers, wholesalers and logistics service providers like CHAPPER healthcare fight counterfeit medicines thus improving patient safety. The regulations help verify the authenticity of each medicinal product manufactured or distributed in Europe.
Speaking about the regulations Jonathan Chapper: CEO of CHAPPER healthcare, said: “We are completely supportive of the new regulations and have everything in place to ensure we are FMD compliant. As part of our preparations CHAPPER healthcare has introduced new state-of-the-art scanning software into our warehouse. Additionally, our operating procedures have been updated to reflect the additional product verification & decommissioning for non-EU exporting requirements”